A prospective randomized study of posterolateral lumbar fusion using Osteogenic Protein-1 (OP-1) versus local autograft with ceramic bone substitute -: Emphasis of surgical exploration and histologic assessment

被引:115
作者
Kanayama, M
Hashimoto, T
Shigenobu, K
Yamane, S
Bauer, TW
Togawa, D
机构
[1] Hakodate Cent Gen Hosp, Dept Orthopaed Surg, Spine Ctr, Hakodate, Hokkaido 0408585, Japan
[2] Cleveland Clin Fdn, Dept Anat Pathol & Orthopaed Surg, Cleveland, OH 44195 USA
关键词
Osteogenic Protein-1 (OP-1); bone morphogenetic protein; posterolateral lumbar fusion; surgical exploration; histology;
D O I
10.1097/01.brs.0000216444.01888.21
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. A prospective, randomized and controlled study. Objectives. To evaluate the osteoinductive property of Osteogenic Protein-1 (OP-1 or BMP-7) and fusion rate in human instrumented posterolateral lumbar fusion through radiographic examination, surgical exploration, and histologic assessment. Summary of Background Data. The use of osteoinductive agents is a current topic in spinal fusion. Numerous preclinical investigations have demonstrated efficacy of osteoinductive proteins in spinal fusion, but few human clinical studies have been reported. Methods. Nineteen patients with L3-L4 or L4-L5 degenerative spondylolisthesis underwent posterolateral lumbar fusion using pedicle screw instrumentation. The patients were randomized to receive either OP-1 Putty (3.5 mg OP-1/g of collagen matrix per side) alone (n=9), or local autograft with HA-TCP granules (n = 10). Fusion status was evaluated using plain radiography and CT scan. Radiographic fusion criteria included less than 5 degrees of angular motion, less than 2 mm of translation, and evidence of bridging bone in the posterolateral lumbar area in which the graft materials were placed following decortication. After a minimum 1-year follow-up, the patients who showed radiographic evidence of fusion underwent instrumentation removal and surgical exploration of the fusion site. Biopsy specimens were taken from the fusion mass and evaluated histologically. Results. Radiographic fusion rate was 7 of 9 OP-1 patients and 9 of 10 control patients. Based on surgical exploration of these 16 patients, new bone formation was macroscopically observed in the posterolateral lumbar region in all cases; however, solid fusion was observed in 4 of 7 OP-1 and 7 of 9 HA-TCP/autograft patients. Histologic assessment demonstrated viable bone in 6 of 7 OP-1 patients. All the control (HA-TCP/autograft) specimens contained viable bone and fibrous tissue surrounding ceramic granules, suggesting slow incorporation of the graft material. Conclusions. In a human posterolateral lumbar spine trial, OP-1 reliably induced viable amounts of new bone formation, but the fusion success rate evaluated by surgical exploration was only 4 of 7.
引用
收藏
页码:1067 / 1074
页数:8
相关论文
共 38 条
[1]   Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion [J].
Akamaru, T ;
Suh, D ;
Boden, SD ;
Kim, HS ;
Minamide, A ;
Louis-Ugbo, J .
SPINE, 2003, 28 (05) :429-434
[2]   Smoking as a predictor of negative outcome in lumbar spinal fusion [J].
Andersen, T ;
Christensen, FB ;
Laursen, M ;
Hansen, ES ;
Bünger, C .
SPINE, 2001, 26 (23) :2623-2628
[3]   CAN LUMBAR SPINE RADIOGRAPHS ACCURATELY DETERMINE FUSION IN POSTOPERATIVE-PATIENTS - CORRELATION OF ROUTINE RADIOGRAPHS WITH A 2ND SURGICAL LOOK AT LUMBAR FUSIONS [J].
BLUMENTHAL, SL ;
GILL, K .
SPINE, 1993, 18 (09) :1186-1189
[4]   Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate [J].
Boden, SD ;
Martin, GJ ;
Morone, MA ;
Ugbo, JL ;
Moskovitz, PA .
SPINE, 1999, 24 (12) :1179-1185
[5]   Ne-osteo bone growth factor for posterolateral lumbar spine fusion: Results from a nonhuman primate study and a prospective human clinical pilot study [J].
Boden, SD ;
Grob, D ;
Damien, C .
SPINE, 2004, 29 (05) :504-514
[6]   Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies [J].
Boden, SD ;
Kang, J ;
Sandhu, H ;
Heller, JG .
SPINE, 2002, 27 (23) :2662-2673
[7]   The use of an osteoinductive growth factor for lumbar spinal fusion .1. Biology of spinal fusion [J].
Boden, SD ;
Schimandle, JH ;
Hutton, WC ;
Chen, MI .
SPINE, 1995, 20 (24) :2626-2632
[8]   THE ROLE OF FUSION AND INSTRUMENTATION IN THE TREATMENT OF DEGENERATIVE SPONDYLOLISTHESIS WITH SPINAL STENOSIS [J].
BRIDWELL, KH ;
SEDGEWICK, TA ;
OBRIEN, MF ;
LENKE, LG ;
BALDUS, C .
JOURNAL OF SPINAL DISORDERS, 1993, 6 (06) :461-472
[9]   Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2 [J].
Burkus, JK ;
Dorchak, JD ;
Sanders, DL .
SPINE, 2003, 28 (04) :372-377
[10]   Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs) [J].
Cheng, HW ;
Jiang, W ;
Phillips, FM ;
Haydon, RC ;
Peng, Y ;
Zhou, L ;
Luu, HH ;
An, NL ;
Breyer, B ;
Vanichakarn, P ;
Szatkowski, JP ;
Park, JY ;
He, TC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A (08) :1544-1552